Cargando…

Cytokine Kinetics in Febrile Neutropenic Children: Insights on the Usefulness as Sepsis Biomarkers, Influence of Filgrastim, and Behavior of the IL-23/IL-17 Pathway

BACKGROUND: The study aimed to describe the kinetics of various cytokines from day 1 to day 14 of the onset of fever in neutropenic children and to evaluate their performances as discriminators of sepsis in the first 24 hours of fever, the possible influence of filgrastim, and the functioning of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Araujo, Orlei Ribeiro, Salomão, Reinaldo, Brunialti, Milena Karina Coló, da Silva, Dafne Cardoso Bourguignon, Senerchia, Andreza Almeida, de Moraes Costa Carlesse, Fabianne Altruda, Petrilli, Antonio Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523193/ https://www.ncbi.nlm.nih.gov/pubmed/28769538 http://dx.doi.org/10.1155/2017/8291316

Ejemplares similares

Sepsis-related acute respiratory distress syndrome in children with cancer: the respiratory dynamics of a devastating condition
por: Arduini, Rodrigo Genaro, et al.
Publicado: (2016)

Increased Percentages of T Helper Cells Producing IL-17 and Monocytes Expressing Markers of Alternative Activation in Patients with Sepsis
por: Colo Brunialti, Milena Karina, et al.
Publicado: (2012)

T helper type cytokines in sepsis: time-shared variance and correlation with organ dysfunction and hospital mortality
por: Costa, Ramon Teixeira, et al.
Publicado: (2019)

Increased Serum IL 6 Associated With Mortality and Cognitive Impairment in Elderly Brazilians
por: Caldeira, Marcelo, et al.
Publicado: (2020)

Epigenetic Regulation in Sepsis, Role in Pathophysiology and Therapeutic Perspective
por: Falcão-Holanda, Renata Brito, et al.
Publicado: (2021)

Downregulation of IL-6 and preserved reactive oxygen species production in human monocytes tolerized by lipopolysaccharide and challenged with Toll-like receptor agonists and whole Gram-negative and Gram-positive bacteria
por: Fernandes, Maria da Luz, et al.
Publicado: (2008)

Flow Cytometry of Human Primary Epidermal and Follicular Keratinocytes
por: Gragnani, Alfredo, et al.
Publicado: (2008)

Transitional B cells and CD21low in patients with ataxia-telangiectasia
por: Bichuetti-Silva, Danielli Christinni, et al.
Publicado: (2015)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes
por: Raheja, Ronak, et al.
Publicado: (2023)

A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital
por: da Silva, Adriana Maria Paixão de Sousa, et al.
Publicado: (2023)

Effect of preoperative pregabalin on analgesia and interleukins after lumbotomy: prospective, randomized, comparative, double-blind study
por: Santiago, Ana Ellen Queiroz, et al.
Publicado: (2019)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
por: Schwartzberg, Lee S, et al.
Publicado: (2018)

Risk Factors Related to Poor Outcomes in the Treatment of Non-conventional Periprosthetic Infection
por: Viola, Dan Carai Maia, et al.
Publicado: (2021)

Plasma levels of IL-6 and IL-10 in septic patients at admission and during follow-up and association with clinical outcomes
por: Costa, RT, et al.
Publicado: (2011)

Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing Chemotherapy
por: Schwartzberg, Lee S., et al.
Publicado: (2018)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
por: Advani, S. H., et al.
Publicado: (2010)

Patterns of Circulating Cytokines and Vascular Markers’ Response in the Presence of COVID-19 in Kidney Transplant Recipients Compared with Non-Transplanted Patients
por: Brunialti, Milena Karina Coló, et al.
Publicado: (2023)

Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
por: Weycker, Derek, et al.
Publicado: (2014)

Effectiveness and Safety of Filgrastim (Neupogen™) versus Filgrastim-aafi (Nivestim™) in Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia: An Observational Cohort Study
por: Al-Rabayah, Abeer A., et al.
Publicado: (2022)

466 Skin lesions in febrile neutropenic patients
por: Yemisen, Mucahit, et al.
Publicado: (2014)

Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
por: Otremba, Burkhard, et al.
Publicado: (2018)

Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia
Publicado: (2021)

Antibiotic prophylaxis in acute childhood leukemia: What is known so far?
por: Dufrayer, Mauro Cesar, et al.
Publicado: (2023)

Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?
por: Dassi, Natália, et al.
Publicado: (2023)

Glucose metabolism is upregulated in the mononuclear cell proteome during sepsis and supports endotoxin-tolerant cell function
por: Ferreira, Bianca Lima, et al.
Publicado: (2022)

Food-borne bacteremic illnesses in febrile neutropenic children
por: Lee, Anselm Chi-wai, et al.
Publicado: (2011)

Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
por: Libuit, Jessica, et al.
Publicado: (2014)

Respiratory Viruses in Febrile Neutropenic Patients with Respiratory Symptoms
por: Meidani, Mohsen, et al.
Publicado: (2018)

Candidemia in Febrile Neutropenic Patients; a Brief Report
por: Yousefi, Maysam, et al.
Publicado: (2018)

Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
por: Sharma, Narendra Kumar, et al.
Publicado: (2019)

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination
por: de Marie, S., et al.
Publicado: (1993)

Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress
por: Santos, Sidneia Sousa, et al.
Publicado: (2022)

Evaluation of febrile neutropenic episodes in adult patients with solid tumors
por: YAPICI, OKTAY, et al.
Publicado: (2016)

Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children
por: Lee, Jina
Publicado: (2016)

Emergency department disposition of non‐neutropenic febrile patients with cancer
por: Bischof, Jason J., et al.
Publicado: (2021)

Patterns of Gene Expression in Peripheral Blood Mononuclear Cells and Outcomes from Patients with Sepsis Secondary to Community Acquired Pneumonia
por: Severino, Patricia, et al.
Publicado: (2014)

Gene expression profiling of mononuclear cells from patients with sepsis secondary to community-acquired pneumonia
por: Severino, Patricia, et al.
Publicado: (2014)

Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia
por: Sharma, Narendra Kumar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qpafs2m6mmrubk6v1gce61gam5